Deals Of The Week: Alnylam/The Medicines Co., Inspiration/Cangene, Pfizer/OxOnc

 
• By Stacy Lawrence, Jessica Merrill, and Sten Stovall

Biogen brings Tysabri fully in-house by using off-shore cash to compensate Irish partner Elan. Plus, the week in biopharma deal-making.

More from Archive

More from Pink Sheet